跳至主要内容
临床试验/JPRN-UMIN000000987
JPRN-UMIN000000987已完成4 期

Effects of long-acting alendronate on osteoporosis with impaired glucose metabolism - Fushimi Bone Study

ational Hospital Organization, Kyoto Medical Center0 个研究点目标入组 100 人开始时间: 2008年2月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
50years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) patient taking bisphosphonates 2) patients contraindicated for alendronate 3) patients under treatment of glucocorticoid or with a history of treatment for 3 years or more. 4) disease states causing secondary osteoporosis: primary hyperparathyroidism, hyperthyroidism, hypogonadism, chronic rheumatic arthritis, multiple myeloma and other hematological diseases,Cushing's syndrome, immobilization, mesotholexate 5) type I diabetes mellitus, diabetes associated with other specific diseases and pregnancy 6) patients not suitable for measuring bone mineral density due to the history of supine bone fracture 7) other various conditions in which the attending doctor decide not suitable for entry.

研究者

发起方
ational Hospital Organization, Kyoto Medical Center

相似试验